
Agenus Schedules Conference Call to Discuss the Company's Minority Cash Holdings at SVB
LEXINGTON, Mass., March 11, 2023 (GLOBE NEWSWIRE) -- Agenus AGEN, a clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, today announced that it will hold a conference call to …